Smoking cessation and nicotine de-addiction are drugs and therapies used in the treatment of withdrawal symptoms associated with the cessation of nicotine. According to the World Health Organization tobacco kills around 6 million people each year and of these almost 5 million deaths are the result of direct tobacco use and approximately 600,000 are the result of passive smoking. Tobacco also derives its users of income, raises healthcare cost and hinder economic development.

Nicotine use also is a risk factor for many diseases and disorders such as cardiovascular diseases, cancer etc. Green tobacco sickness, caused by nicotine absorption through the skin by the handling of wet tobacco leaves in tobacco industry is also a concern especially among children. Tobacco quitting assistance in the form of national cessation services with cost-coverage are available in only 24 countries, representing 15% of the world's population. Only 42 countries, representing 19% of the world's population, have instituted advertisement regulations such as pictorial warnings.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2737

The other market driving factors include increasing desire and drives to quit smoking and active role of social and health organizations against tobacco use, the prohibitive costs due to high taxes leveraged on tobacco products, social stigma imposed on tobacco users etc. The other critical market driving factor is the huge number of unmet needs. The World Health Organization (WHO), estimates around 1,100 million smokers worldwide with emerging economies accounting for around 70% of the global smoker population.

The market trends include development of better products such as nicotine gums and patches, e-cigarette’s etc.

The market for Middle East and Africa smoking cessation and nicotine de-addiction was estimated to be around $ 1040 million in 2016. Taking all factors into consideration, we expect the Middle East and Africa smoking cessation and nicotine de-addiction market to reach around $ 2108.38 million, by 2022 growing at a CAGR of 12.5%

Study Objectives of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market

To provide detail analysis of the market structure along with forecast for the next 6 years of various segments and sub-segments of the Middle East and Africa smoking cessation and nicotine de-addiction market.
To provide insights about factors affecting the market growth.
To analyze the market based on various analyses which includes price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of Middle East and Africa smoking cessation and nicotine de-addiction market’s segments and sub-segments. To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the Middle East and Africa smoking cessation and nicotine de-addiction market by treatment (pharmacological, therapies and others), by product type (drugs, inhalers, patches, sprays and gums and others) and by distribution channels (pharmacies, online, de-addiction centers) and other sub segments.
To provide overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape of the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments globally.
Key Players of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market
Some of the key players in this market are Pfizer Inc, VMR Products LLC, Johnson & Johnson, Novartis International AG, Cipla Inc., and GlaxoSmithKline plc. Nicotek LLC., and Lorillard, Inc. and others.

Segments:
Middle East and Africa smoking cessation and nicotine de-addiction products market has been segmented on the basis of treatment which comprises of pharmacological, therapies etc. On the basis of product type; market is segmented into drugs, inhalers, patches, sprays and gums and others. On the basis of distribution channels; market is segmented into pharmacies, online and de-addiction centers.

Regional Analysis of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market
UAE is the largest market in the entire Middle East and Africa smoking cessation and nicotine de-addiction products market closely followed by Egypt. Algeria and South Africa followed by Ethiopia are fastest growing markets in Africa. The rest of Africa market however has maximum population with unmet medical needs.

The report for Middle East and Africa smoking cessation and nicotine de-addiction market by Market Research Future comprises extensive primary research along with detail analysis of qualitative as well as quantitative aspects given by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provide detail information about and strategies used by top key players in the industry. The report also gives a broad study of different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mea-smoking-cessation-nicotine-de-addiction-market-2737

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]